2 - 5 SEPTEMBER
HomeProgrammeProgramme At-a-glance

Programme At-a-glance

ILCA 15th Annual Conference Scientific Programme

The ILCA AC 2021 scientific programme will offer to participants with a large of different sessions dedicated to better prevent and treat liver cancer.

Scientific and medical experts from around the world will exchange the latest scientific advances and best practices in liver cancer research and care.

The 15th multidisciplinary Annual Conference format will present a mix of scientific and educational session and live debates and presentations.

Thursday September 2, 2021
September 2, 2021
14:00 - 14:15
Welcome Address
14:00
14:15
Welcome Address

Speaker: Bruno Sangro

14:15 - 14:30
Pre-conference workshop:
Rare liver tumors
14:15
15:30
Pre-conference workshop:
Rare liver tumors

Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi

Fibrolamellar Carcinoma
Clinical aspects of fibrollamelar hepatocellular carcinoma - Ghassan K. Abou-Alfa
Basic/Translation aspects of fibrolamelar hepatocellular carcinoma - Sandford Simon

Cholangio Mix Tumor

Hepatoblastoma
Basic aspect - Jessica Zucman-Rossi

14:30 - 14:45
14:45 - 15:00
15:00 - 15:15
15:15 - 15:30
15:30 - 15:45
Break
15:30
15:45
15:45 - 16:00
Pre-conference workshop:
Rare liver tumors
15:45
16:30
Pre-conference workshop:
Rare liver tumors

Rare hepatic Tumors

Patient Advocacy
Patient advocacy for patients with fibrolamellar HCC - Mark Furth

Questions & Answers

16:00 - 16:15
16:15 - 16:30
16:30 - 16:45
Break
16:30
16:45
16:45 - 17:00
Single Topic Workshop
16:45
17:45
17:00 - 17:15
17:15 - 17:30
17:30 - 17:45
17:45 - 18:00
ILCA / EASL Symposium
17:45
18:30
18:00 - 18:15
18:15 - 18:30
18:30 - 18:45
Industry Symposium
18:30
19:30
18:45 - 19:00
19:00 - 19:15
19:15 - 19:30

September 2, 2021

  • Welcome Address
    14:00 - 14:15
  • Pre-conference workshop:
    Rare liver tumors
    14:15 - 15:30
  • Break
    15:30 - 15:45
  • Pre-conference workshop:
    Rare liver tumors
    15:45 - 16:30
  • Break
    16:30 - 16:45
  • Single Topic Workshop
    16:45 - 17:45
  • ILCA / EASL Symposium
    17:45 - 18:30
  • Industry Symposium
    18:30 - 19:30
No events available!
September 2, 2021
05:00 - 05:15
Welcome Address
05:00
05:15
Welcome Address

Speaker: Bruno Sangro

05:15 - 05:30
Pre-conference workshop:
Rare liver tumors
05:15
06:30
Pre-conference workshop:
Rare liver tumors

Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi

Fibrolamellar Carcinoma
Clinical aspects of fibrollamelar hepatocellular carcinoma - Ghassan K. Abou-Alfa
Basic/Translation aspects of fibrolamelar hepatocellular carcinoma - Sandford Simon

Cholangio Mix Tumor

Hepatoblastoma
Basic aspect - Jessica Zucman-Rossi

05:30 - 05:45
05:45 - 06:00
06:00 - 06:15
06:15 - 06:30
06:30 - 06:45
Break
06:30
06:45
06:45 - 07:00
Pre-conference workshop:
Rare liver tumors
06:45
07:30
Pre-conference workshop:
Rare liver tumors

Rare hepatic Tumors

Patient Advocacy
Patient advocacy for patients with fibrolamellar HCC - Mark Furth

Questions & Answers

07:00 - 07:15
07:15 - 07:30
07:30 - 07:45
Break
07:30
07:45
07:45 - 08:00
Single Topic Workshop
07:45
08:45
08:00 - 08:15
08:15 - 08:30
08:30 - 08:45
08:45 - 09:00
ILCA / EASL Symposium
08:45
09:30
09:00 - 09:15
09:15 - 09:30
09:30 - 09:45
Industry Symposium
09:30
10:30
09:45 - 10:00
10:00 - 10:15
10:15 - 10:30

September 2, 2021

  • Welcome Address
    05:00 - 05:15
  • Pre-conference workshop:
    Rare liver tumors
    05:15 - 06:30
  • Break
    06:30 - 06:45
  • Pre-conference workshop:
    Rare liver tumors
    06:45 - 07:30
  • Break
    07:30 - 07:45
  • Single Topic Workshop
    07:45 - 08:45
  • ILCA / EASL Symposium
    08:45 - 09:30
  • Industry Symposium
    09:30 - 10:30
No events available!
September 2, 2021
08:00 - 08:15
Welcome Address
08:00
08:15
Welcome Address

Speaker: Bruno Sangro

08:15 - 08:30
Pre-conference workshop:
Rare liver tumors
08:15
09:30
Pre-conference workshop:
Rare liver tumors

Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi

Fibrolamellar Carcinoma
Clinical aspects of fibrollamelar hepatocellular carcinoma - Ghassan K. Abou-Alfa
Basic/Translation aspects of fibrolamelar hepatocellular carcinoma - Sandford Simon

Cholangio Mix Tumor

Hepatoblastoma
Basic aspect - Jessica Zucman-Rossi

08:30 - 08:45
08:45 - 09:00
09:00 - 09:15
09:15 - 09:30
09:30 - 09:45
Break
09:30
09:45
09:45 - 10:00
Pre-conference workshop:
Rare liver tumors
09:45
10:30
Pre-conference workshop:
Rare liver tumors

Rare hepatic Tumors

Patient Advocacy
Patient advocacy for patients with fibrolamellar HCC - Mark Furth

Questions & Answers

10:00 - 10:15
10:15 - 10:30
10:30 - 10:45
Break
10:30
10:45
10:45 - 11:00
Single Topic Workshop
10:45
11:45
11:00 - 11:15
11:15 - 11:30
11:30 - 11:45
11:45 - 12:00
ILCA / EASL Symposium
11:45
12:30
12:00 - 12:15
12:15 - 12:30
12:30 - 12:45
Industry Symposium
12:30
13:30
12:45 - 13:00
13:00 - 13:15
13:15 - 13:30

September 2, 2021

  • Welcome Address
    08:00 - 08:15
  • Pre-conference workshop:
    Rare liver tumors
    08:15 - 09:30
  • Break
    09:30 - 09:45
  • Pre-conference workshop:
    Rare liver tumors
    09:45 - 10:30
  • Break
    10:30 - 10:45
  • Single Topic Workshop
    10:45 - 11:45
  • ILCA / EASL Symposium
    11:45 - 12:30
  • Industry Symposium
    12:30 - 13:30
No events available!
September 2, 2021
20:00 - 20:15
Welcome Address
20:00
20:15
Welcome Address

Speaker: Bruno Sangro

20:15 - 20:30
Pre-conference workshop:
Rare liver tumors
20:15
21:30
Pre-conference workshop:
Rare liver tumors

Moderators: Ghassan K. Abou-Alfa, Jessica Zucman-Rossi

Fibrolamellar Carcinoma
Clinical aspects of fibrollamelar hepatocellular carcinoma - Ghassan K. Abou-Alfa
Basic/Translation aspects of fibrolamelar hepatocellular carcinoma - Sandford Simon

Cholangio Mix Tumor

Hepatoblastoma
Basic aspect - Jessica Zucman-Rossi

20:30 - 20:45
20:45 - 21:00
21:00 - 21:15
21:15 - 21:30
21:30 - 21:45
Break
21:30
21:45
21:45 - 22:00
Pre-conference workshop:
Rare liver tumors
21:45
22:30
Pre-conference workshop:
Rare liver tumors

Rare hepatic Tumors

Patient Advocacy
Patient advocacy for patients with fibrolamellar HCC - Mark Furth

Questions & Answers

22:00 - 22:15
22:15 - 22:30
22:30 - 22:45
Break
22:30
22:45
22:45 - 23:00
Single Topic Workshop
22:45
23:45
23:00 - 23:15
23:15 - 23:30
23:30 - 23:45
23:45 - 00:00
ILCA / EASL Symposium
23:45
00:30
00:00 - 00:15
00:15 - 00:30

September 2, 2021

  • Welcome Address
    20:00 - 20:15
  • Pre-conference workshop:
    Rare liver tumors
    20:15 - 21:30
  • Break
    21:30 - 21:45
  • Pre-conference workshop:
    Rare liver tumors
    21:45 - 22:30
  • Break
    22:30 - 22:45
  • Single Topic Workshop
    22:45 - 23:45
  • ILCA / EASL Symposium
    23:45 - 00:30
No events available!
September 2, 2021
00:30 - 00:45
Industry Symposium
00:30
01:30
00:45 - 01:00
01:00 - 01:15
01:15 - 01:30

September 2, 2021

  • Industry Symposium
    00:30 - 01:30
No events available!
Friday September 3, 2021
September 3, 2021
13:45 - 14:00
Daily wrap up
13:45
14:00
14:00 - 14:15
Industry Symposium
14:00
15:00
14:15 - 14:30
14:30 - 14:45
14:45 - 15:00
15:00 - 15:15
Basic State of the Art
15:00
15:30
Basic State of the Art

Telomeres and Cancer - Maria Blasco

15:15 - 15:30
15:30 - 15:45
Break
15:30
15:45
15:45 - 16:00
Young Investigator Session
15:45
16:45
16:00 - 16:15
16:15 - 16:30
16:30 - 16:45
16:45 - 17:00
Break
16:45
17:00
17:00 - 17:15
Best Basic / Translational Poster session
17:00
18:00
17:15 - 17:30
17:30 - 17:45
17:45 - 18:00
18:00 - 18:15
Break
18:00
18:15
18:15 - 18:30
Presidential Address & Junior Investigator Awards
18:15
18:45
18:30 - 18:45
18:45 - 19:00
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?
18:45
19:30
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?

Chairs: Robert T. Schwabe, Amaia Lujambio

Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH
Ploidy heterogeneity and HCC prevention - Hao Zhu, UTSW
Tumor microenvironment in the development and progression of cholangiocarcinoma - Silvia Affo

19:00 - 19:15
19:15 - 19:30
19:30 - 19:45
Industry Symposium
19:30
20:30
19:45 - 20:00
20:00 - 20:15
20:15 - 20:30

September 3, 2021

  • Daily wrap up
    13:45 - 14:00
  • Industry Symposium
    14:00 - 15:00
  • Basic State of the Art
    15:00 - 15:30
  • Break
    15:30 - 15:45
  • Young Investigator Session
    15:45 - 16:45
  • Break
    16:45 - 17:00
  • Best Basic / Translational Poster session
    17:00 - 18:00
  • Break
    18:00 - 18:15
  • Presidential Address & Junior Investigator Awards
    18:15 - 18:45
  • Basic Science Symposium:
    What has single cell genomics contributed to our understanding of liver cancer?
    18:45 - 19:30
  • Industry Symposium
    19:30 - 20:30
No events available!
September 3, 2021
04:45 - 05:00
Daily wrap up
04:45
05:00
05:00 - 05:15
Industry Symposium
05:00
06:00
05:15 - 05:30
05:30 - 05:45
05:45 - 06:00
06:00 - 06:15
Basic State of the Art
06:00
06:30
Basic State of the Art

Telomeres and Cancer - Maria Blasco

06:15 - 06:30
06:30 - 06:45
Break
06:30
06:45
06:45 - 07:00
Young Investigator Session
06:45
07:45
07:00 - 07:15
07:15 - 07:30
07:30 - 07:45
07:45 - 08:00
Break
07:45
08:00
08:00 - 08:15
Best Basic / Translational Poster session
08:00
09:00
08:15 - 08:30
08:30 - 08:45
08:45 - 09:00
09:00 - 09:15
Break
09:00
09:15
09:15 - 09:30
Presidential Address & Junior Investigator Awards
09:15
09:45
09:30 - 09:45
09:45 - 10:00
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?
09:45
10:30
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?

Chairs: Robert T. Schwabe, Amaia Lujambio

Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH
Ploidy heterogeneity and HCC prevention - Hao Zhu, UTSW
Tumor microenvironment in the development and progression of cholangiocarcinoma - Silvia Affo

10:00 - 10:15
10:15 - 10:30
10:30 - 10:45
Industry Symposium
10:30
11:30
10:45 - 11:00
11:00 - 11:15
11:15 - 11:30

September 3, 2021

  • Daily wrap up
    04:45 - 05:00
  • Industry Symposium
    05:00 - 06:00
  • Basic State of the Art
    06:00 - 06:30
  • Break
    06:30 - 06:45
  • Young Investigator Session
    06:45 - 07:45
  • Break
    07:45 - 08:00
  • Best Basic / Translational Poster session
    08:00 - 09:00
  • Break
    09:00 - 09:15
  • Presidential Address & Junior Investigator Awards
    09:15 - 09:45
  • Basic Science Symposium:
    What has single cell genomics contributed to our understanding of liver cancer?
    09:45 - 10:30
  • Industry Symposium
    10:30 - 11:30
No events available!
September 3, 2021
07:45 - 08:00
Daily wrap up
07:45
08:00
08:00 - 08:15
Industry Symposium
08:00
09:00
08:15 - 08:30
08:30 - 08:45
08:45 - 09:00
09:00 - 09:15
Basic State of the Art
09:00
09:30
Basic State of the Art

Telomeres and Cancer - Maria Blasco

09:15 - 09:30
09:30 - 09:45
Break
09:30
09:45
09:45 - 10:00
Young Investigator Session
09:45
10:45
10:00 - 10:15
10:15 - 10:30
10:30 - 10:45
10:45 - 11:00
Break
10:45
11:00
11:00 - 11:15
Best Basic / Translational Poster session
11:00
12:00
11:15 - 11:30
11:30 - 11:45
11:45 - 12:00
12:00 - 12:15
Break
12:00
12:15
12:15 - 12:30
Presidential Address & Junior Investigator Awards
12:15
12:45
12:30 - 12:45
12:45 - 13:00
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?
12:45
13:30
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?

Chairs: Robert T. Schwabe, Amaia Lujambio

Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH
Ploidy heterogeneity and HCC prevention - Hao Zhu, UTSW
Tumor microenvironment in the development and progression of cholangiocarcinoma - Silvia Affo

13:00 - 13:15
13:15 - 13:30
13:30 - 13:45
Industry Symposium
13:30
14:30
13:45 - 14:00
14:00 - 14:15
14:15 - 14:30

September 3, 2021

  • Daily wrap up
    07:45 - 08:00
  • Industry Symposium
    08:00 - 09:00
  • Basic State of the Art
    09:00 - 09:30
  • Break
    09:30 - 09:45
  • Young Investigator Session
    09:45 - 10:45
  • Break
    10:45 - 11:00
  • Best Basic / Translational Poster session
    11:00 - 12:00
  • Break
    12:00 - 12:15
  • Presidential Address & Junior Investigator Awards
    12:15 - 12:45
  • Basic Science Symposium:
    What has single cell genomics contributed to our understanding of liver cancer?
    12:45 - 13:30
  • Industry Symposium
    13:30 - 14:30
No events available!
September 3, 2021
19:45 - 20:00
Daily wrap up
19:45
20:00
20:00 - 20:15
Industry Symposium
20:00
21:00
20:15 - 20:30
20:30 - 20:45
20:45 - 21:00
21:00 - 21:15
Basic State of the Art
21:00
21:30
Basic State of the Art

Telomeres and Cancer - Maria Blasco

21:15 - 21:30
21:30 - 21:45
Break
21:30
21:45
21:45 - 22:00
Young Investigator Session
21:45
22:45
22:00 - 22:15
22:15 - 22:30
22:30 - 22:45
22:45 - 23:00
Break
22:45
23:00
23:00 - 23:15
Best Basic / Translational Poster session
23:00
00:00
23:15 - 23:30
23:30 - 23:45
23:45 - 00:00
00:00 - 00:15
Break
00:00
00:15

September 3, 2021

  • Daily wrap up
    19:45 - 20:00
  • Industry Symposium
    20:00 - 21:00
  • Basic State of the Art
    21:00 - 21:30
  • Break
    21:30 - 21:45
  • Young Investigator Session
    21:45 - 22:45
  • Break
    22:45 - 23:00
  • Best Basic / Translational Poster session
    23:00 - 00:00
  • Break
    00:00 - 00:15
No events available!
September 3, 2021
00:15 - 00:30
Presidential Address & Junior Investigator Awards
00:15
00:45
00:30 - 00:45
00:45 - 01:00
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?
00:45
01:30
Basic Science Symposium:
What has single cell genomics contributed to our understanding of liver cancer?

Chairs: Robert T. Schwabe, Amaia Lujambio

Single cell genomics and response to therapies in hepatocellular carcinoma - Xin Wei Wang, NIH
Ploidy heterogeneity and HCC prevention - Hao Zhu, UTSW
Tumor microenvironment in the development and progression of cholangiocarcinoma - Silvia Affo

01:00 - 01:15
01:15 - 01:30
01:30 - 01:45
Industry Symposium
01:30
02:30
01:45 - 02:00
02:00 - 02:15
02:15 - 02:30

September 3, 2021

  • Presidential Address & Junior Investigator Awards
    00:15 - 00:45
  • Basic Science Symposium:
    What has single cell genomics contributed to our understanding of liver cancer?
    00:45 - 01:30
  • Industry Symposium
    01:30 - 02:30
No events available!
Saturday September 4, 2021
September 4, 2021
13:45 - 14:00
Daily wrap up
13:45
14:00
14:00 - 14:15
Industry Symposium
14:00
15:00
14:15 - 14:30
14:30 - 14:45
14:45 - 15:00
15:00 - 15:15
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research
15:00
16:00
15:15 - 15:30
15:30 - 15:45
15:45 - 16:00
16:00 - 16:15
Break
16:00
16:15
16:15 - 16:30
Clinical State of the Art
16:15
16:45
Clinical State of the Art

Past, present, and future of transplant oncology - Vincenzo Mazaferro

16:30 - 16:45
16:45 - 17:00
Break
16:45
17:00
17:00 - 17:15
Best Clinical Poster session
17:00
18:00
17:15 - 17:30
17:30 - 17:45
17:45 - 18:00
18:00 - 18:15
Break
18:00
18:15
18:15 - 18:30
ILCA Tumor Board
18:15
19:00
ILCA Tumor Board

Chair: Pierre Nahon
Speakers: Sasan Roayaie, Ann-li Chen

18:30 - 18:45
18:45 - 19:00
19:00 - 19:15
General Session 2:
Epidemiology, Staging and Prognosis
19:00
20:30
19:15 - 19:30
19:30 - 19:45
19:45 - 20:00
20:00 - 20:15
20:15 - 20:30

September 4, 2021

  • Daily wrap up
    13:45 - 14:00
  • Industry Symposium
    14:00 - 15:00
  • General Session 1:
    Molecular Pathogenesis, Cell Biology and Translational Research
    15:00 - 16:00
  • Break
    16:00 - 16:15
  • Clinical State of the Art
    16:15 - 16:45
  • Break
    16:45 - 17:00
  • Best Clinical Poster session
    17:00 - 18:00
  • Break
    18:00 - 18:15
  • ILCA Tumor Board
    18:15 - 19:00
  • General Session 2:
    Epidemiology, Staging and Prognosis
    19:00 - 20:30
No events available!
September 4, 2021
04:45 - 05:00
Daily wrap up
04:45
05:00
05:00 - 05:15
Industry Symposium
05:00
06:00
05:15 - 05:30
05:30 - 05:45
05:45 - 06:00
06:00 - 06:15
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research
06:00
07:00
06:15 - 06:30
06:30 - 06:45
06:45 - 07:00
07:00 - 07:15
Break
07:00
07:15
07:15 - 07:30
Clinical State of the Art
07:15
07:45
Clinical State of the Art

Past, present, and future of transplant oncology - Vincenzo Mazaferro

07:30 - 07:45
07:45 - 08:00
Break
07:45
08:00
08:00 - 08:15
Best Clinical Poster session
08:00
09:00
08:15 - 08:30
08:30 - 08:45
08:45 - 09:00
09:00 - 09:15
Break
09:00
09:15
09:15 - 09:30
ILCA Tumor Board
09:15
10:00
ILCA Tumor Board

Chair: Pierre Nahon
Speakers: Sasan Roayaie, Ann-li Chen

09:30 - 09:45
09:45 - 10:00
10:00 - 10:15
General Session 2:
Epidemiology, Staging and Prognosis
10:00
11:30
10:15 - 10:30
10:30 - 10:45
10:45 - 11:00
11:00 - 11:15
11:15 - 11:30

September 4, 2021

  • Daily wrap up
    04:45 - 05:00
  • Industry Symposium
    05:00 - 06:00
  • General Session 1:
    Molecular Pathogenesis, Cell Biology and Translational Research
    06:00 - 07:00
  • Break
    07:00 - 07:15
  • Clinical State of the Art
    07:15 - 07:45
  • Break
    07:45 - 08:00
  • Best Clinical Poster session
    08:00 - 09:00
  • Break
    09:00 - 09:15
  • ILCA Tumor Board
    09:15 - 10:00
  • General Session 2:
    Epidemiology, Staging and Prognosis
    10:00 - 11:30
No events available!
September 4, 2021
07:45 - 08:00
Daily wrap up
07:45
08:00
08:00 - 08:15
Industry Symposium
08:00
09:00
08:15 - 08:30
08:30 - 08:45
08:45 - 09:00
09:00 - 09:15
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research
09:00
10:00
09:15 - 09:30
09:30 - 09:45
09:45 - 10:00
10:00 - 10:15
Break
10:00
10:15
10:15 - 10:30
Clinical State of the Art
10:15
10:45
Clinical State of the Art

Past, present, and future of transplant oncology - Vincenzo Mazaferro

10:30 - 10:45
10:45 - 11:00
Break
10:45
11:00
11:00 - 11:15
Best Clinical Poster session
11:00
12:00
11:15 - 11:30
11:30 - 11:45
11:45 - 12:00
12:00 - 12:15
Break
12:00
12:15
12:15 - 12:30
ILCA Tumor Board
12:15
13:00
ILCA Tumor Board

Chair: Pierre Nahon
Speakers: Sasan Roayaie, Ann-li Chen

12:30 - 12:45
12:45 - 13:00
13:00 - 13:15
General Session 2:
Epidemiology, Staging and Prognosis
13:00
14:30
13:15 - 13:30
13:30 - 13:45
13:45 - 14:00
14:00 - 14:15
14:15 - 14:30

September 4, 2021

  • Daily wrap up
    07:45 - 08:00
  • Industry Symposium
    08:00 - 09:00
  • General Session 1:
    Molecular Pathogenesis, Cell Biology and Translational Research
    09:00 - 10:00
  • Break
    10:00 - 10:15
  • Clinical State of the Art
    10:15 - 10:45
  • Break
    10:45 - 11:00
  • Best Clinical Poster session
    11:00 - 12:00
  • Break
    12:00 - 12:15
  • ILCA Tumor Board
    12:15 - 13:00
  • General Session 2:
    Epidemiology, Staging and Prognosis
    13:00 - 14:30
No events available!
September 4, 2021
19:45 - 20:00
Daily wrap up
19:45
20:00
20:00 - 20:15
Industry Symposium
20:00
21:00
20:15 - 20:30
20:30 - 20:45
20:45 - 21:00
21:00 - 21:15
General Session 1:
Molecular Pathogenesis, Cell Biology and Translational Research
21:00
22:00
21:15 - 21:30
21:30 - 21:45
21:45 - 22:00
22:00 - 22:15
Break
22:00
22:15
22:15 - 22:30
Clinical State of the Art
22:15
22:45
Clinical State of the Art

Past, present, and future of transplant oncology - Vincenzo Mazaferro

22:30 - 22:45
22:45 - 23:00
Break
22:45
23:00
23:00 - 23:15
Best Clinical Poster session
23:00
00:00
23:15 - 23:30
23:30 - 23:45
23:45 - 00:00
00:00 - 00:15
Break
00:00
00:15

September 4, 2021

  • Daily wrap up
    19:45 - 20:00
  • Industry Symposium
    20:00 - 21:00
  • General Session 1:
    Molecular Pathogenesis, Cell Biology and Translational Research
    21:00 - 22:00
  • Break
    22:00 - 22:15
  • Clinical State of the Art
    22:15 - 22:45
  • Break
    22:45 - 23:00
  • Best Clinical Poster session
    23:00 - 00:00
  • Break
    00:00 - 00:15
No events available!
September 4, 2021
00:15 - 00:30
ILCA Tumor Board
00:15
01:00
ILCA Tumor Board

Chair: Pierre Nahon
Speakers: Sasan Roayaie, Ann-li Chen

00:30 - 00:45
00:45 - 01:00
01:00 - 01:15
General Session 2:
Epidemiology, Staging and Prognosis
01:00
02:30
01:15 - 01:30
01:30 - 01:45
01:45 - 02:00
02:00 - 02:15
02:15 - 02:30

September 4, 2021

  • ILCA Tumor Board
    00:15 - 01:00
  • General Session 2:
    Epidemiology, Staging and Prognosis
    01:00 - 02:30
No events available!
Sunday September 5, 2021
September 5, 2021
13:45 - 14:00
Daily wrap up
13:45
14:00
14:00 - 14:15
Industry Symposium
14:00
15:00
14:15 - 14:30
14:30 - 14:45
14:45 - 15:00
15:00 - 15:15
General Session 3:
Diagnosis, Imaging and Biomarkers
15:00
16:30
15:15 - 15:30
15:30 - 15:45
15:45 - 16:00
16:00 - 16:15
16:15 - 16:30
16:30 - 16:45
Break
16:30
16:45
16:45 - 17:00
ILCA Debates
16:45
17:30
17:00 - 17:15
17:15 - 17:30
17:30 - 17:45
Break
17:30
17:45
17:45 - 18:00
Clinical Science Symposium:
The future of combination therapies in HCC
17:45
18:45
18:00 - 18:15
18:15 - 18:30
18:30 - 18:45
18:45 - 19:00
Break
18:45
19:00
19:00 - 19:15
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress
19:00
20:30
19:15 - 19:30
19:30 - 19:45
19:45 - 20:00
20:00 - 20:15
20:15 - 20:30
20:30 - 20:45
Farewell Address
20:30
20:45

September 5, 2021

  • Daily wrap up
    13:45 - 14:00
  • Industry Symposium
    14:00 - 15:00
  • General Session 3:
    Diagnosis, Imaging and Biomarkers
    15:00 - 16:30
  • Break
    16:30 - 16:45
  • ILCA Debates
    16:45 - 17:30
  • Break
    17:30 - 17:45
  • Clinical Science Symposium:
    The future of combination therapies in HCC
    17:45 - 18:45
  • Break
    18:45 - 19:00
  • General Session 4:
    Therapy & Miscellaneous & Clinical Trials in progress
    19:00 - 20:30
  • Farewell Address
    20:30 - 20:45
No events available!
September 5, 2021
04:45 - 05:00
Daily wrap up
04:45
05:00
05:00 - 05:15
Industry Symposium
05:00
06:00
05:15 - 05:30
05:30 - 05:45
05:45 - 06:00
06:00 - 06:15
General Session 3:
Diagnosis, Imaging and Biomarkers
06:00
07:30
06:15 - 06:30
06:30 - 06:45
06:45 - 07:00
07:00 - 07:15
07:15 - 07:30
07:30 - 07:45
Break
07:30
07:45
07:45 - 08:00
ILCA Debates
07:45
08:30
08:00 - 08:15
08:15 - 08:30
08:30 - 08:45
Break
08:30
08:45
08:45 - 09:00
Clinical Science Symposium:
The future of combination therapies in HCC
08:45
09:45
09:00 - 09:15
09:15 - 09:30
09:30 - 09:45
09:45 - 10:00
Break
09:45
10:00
10:00 - 10:15
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress
10:00
11:30
10:15 - 10:30
10:30 - 10:45
10:45 - 11:00
11:00 - 11:15
11:15 - 11:30
11:30 - 11:45
Farewell Address
11:30
11:45

September 5, 2021

  • Daily wrap up
    04:45 - 05:00
  • Industry Symposium
    05:00 - 06:00
  • General Session 3:
    Diagnosis, Imaging and Biomarkers
    06:00 - 07:30
  • Break
    07:30 - 07:45
  • ILCA Debates
    07:45 - 08:30
  • Break
    08:30 - 08:45
  • Clinical Science Symposium:
    The future of combination therapies in HCC
    08:45 - 09:45
  • Break
    09:45 - 10:00
  • General Session 4:
    Therapy & Miscellaneous & Clinical Trials in progress
    10:00 - 11:30
  • Farewell Address
    11:30 - 11:45
No events available!
September 5, 2021
07:45 - 08:00
Daily wrap up
07:45
08:00
08:00 - 08:15
Industry Symposium
08:00
09:00
08:15 - 08:30
08:30 - 08:45
08:45 - 09:00
09:00 - 09:15
General Session 3:
Diagnosis, Imaging and Biomarkers
09:00
10:30
09:15 - 09:30
09:30 - 09:45
09:45 - 10:00
10:00 - 10:15
10:15 - 10:30
10:30 - 10:45
Break
10:30
10:45
10:45 - 11:00
ILCA Debates
10:45
11:30
11:00 - 11:15
11:15 - 11:30
11:30 - 11:45
Break
11:30
11:45
11:45 - 12:00
Clinical Science Symposium:
The future of combination therapies in HCC
11:45
12:45
12:00 - 12:15
12:15 - 12:30
12:30 - 12:45
12:45 - 13:00
Break
12:45
13:00
13:00 - 13:15
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress
13:00
14:30
13:15 - 13:30
13:30 - 13:45
13:45 - 14:00
14:00 - 14:15
14:15 - 14:30
14:30 - 14:45
Farewell Address
14:30
14:45

September 5, 2021

  • Daily wrap up
    07:45 - 08:00
  • Industry Symposium
    08:00 - 09:00
  • General Session 3:
    Diagnosis, Imaging and Biomarkers
    09:00 - 10:30
  • Break
    10:30 - 10:45
  • ILCA Debates
    10:45 - 11:30
  • Break
    11:30 - 11:45
  • Clinical Science Symposium:
    The future of combination therapies in HCC
    11:45 - 12:45
  • Break
    12:45 - 13:00
  • General Session 4:
    Therapy & Miscellaneous & Clinical Trials in progress
    13:00 - 14:30
  • Farewell Address
    14:30 - 14:45
No events available!
September 5, 2021
19:45 - 20:00
Daily wrap up
19:45
20:00
20:00 - 20:15
Industry Symposium
20:00
21:00
20:15 - 20:30
20:30 - 20:45
20:45 - 21:00
21:00 - 21:15
General Session 3:
Diagnosis, Imaging and Biomarkers
21:00
22:30
21:15 - 21:30
21:30 - 21:45
21:45 - 22:00
22:00 - 22:15
22:15 - 22:30
22:30 - 22:45
Break
22:30
22:45
22:45 - 23:00
ILCA Debates
22:45
23:30
23:00 - 23:15
23:15 - 23:30
23:30 - 23:45
Break
23:30
23:45
23:45 - 00:00
Clinical Science Symposium:
The future of combination therapies in HCC
23:45
00:45
00:00 - 00:15
00:15 - 00:30
00:30 - 00:45

September 5, 2021

  • Daily wrap up
    19:45 - 20:00
  • Industry Symposium
    20:00 - 21:00
  • General Session 3:
    Diagnosis, Imaging and Biomarkers
    21:00 - 22:30
  • Break
    22:30 - 22:45
  • ILCA Debates
    22:45 - 23:30
  • Break
    23:30 - 23:45
  • Clinical Science Symposium:
    The future of combination therapies in HCC
    23:45 - 00:45
No events available!
September 5, 2021
00:45 - 01:00
Break
00:45
01:00
01:00 - 01:15
General Session 4:
Therapy & Miscellaneous & Clinical Trials in progress
01:00
02:30
01:15 - 01:30
01:30 - 01:45
01:45 - 02:00
02:00 - 02:15
02:15 - 02:30
02:30 - 02:45
Farewell Address
02:30
02:45

September 5, 2021

  • Break
    00:45 - 01:00
  • General Session 4:
    Therapy & Miscellaneous & Clinical Trials in progress
    01:00 - 02:30
  • Farewell Address
    02:30 - 02:45
No events available!
Copyright © ILCA 2021